ASX:PCK

PainChek (PCK) Stock Price, News & Analysis

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PCK stock logo

About PainChek Stock (ASX:PCK)

PainChek Limited develops and commercialized mobile medical device applications that provides pain assessment for individuals in Australia and internationally. The company offers PainChek, which uses camera in smartphones and tablets for facial scan that is analyzed in real time using facial recognition software to indicate the presence of the pain. It serves patients suffering with dementia and pre-verbal infants. The company was formerly known as ePAT Technologies Ltd and changed its name to PainChek Limited in January 2018. PainChek Limited is based in Sydney, Australia.

PCK Stock News Headlines

PainChek leads innovation in AI-based pain assessment
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Neena Pack
Why did this ASX biotech stock explode 36% today?
Exposed: 10 CENT Crypto to Explode April 20th?
Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin
Healthtech PainChek seeks equity injection
MagSafe Battery Pack
35 Essentials for Your 2023 Cruise
PainChek Limited (PCK.AX)
We're Keeping An Eye On PainChek's (ASX:PCK) Cash Burn Rate
When Will PainChek Limited (ASX:PCK) Become Profitable?
Total Brain Limited (TTB.AX)
See More Headlines
Receive PCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PainChek and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-7,770,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$2.48 million

Miscellaneous

Outstanding Shares
1,640,000,000
Free Float
N/A
Optionable
Not Optionable
Beta
0.37
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Mr. Philip Daffas B.Sc.
    Dip EENG, GAICD, M.B.A., MD, CEO & Director
  • Mr. Iain McAdam
    Chief Financial Officer
  • Mr. Andrew Hoggan
    Manager & Head of Operations
  • Mr. Scott Robertson M.B.A.
    Chief Technology Officer
  • Prof. Jeff Hughes Ph.D.
    Chief Scientific Officer
  • Mr. David Allsopp
    Head of Business Development
  • Ms. Natalie Climo
    Company Secretary

This page (ASX:PCK) was last updated on 4/24/2024 by MarketBeat.com Staff

From Our Partners